- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Proof-of-Concept, Open-label Study to Assess the Safety and Efficacy of Batoclimab in Participants with Graves’ Disease (GD)
This study is testing a new medicine, Batoclimab, for Graves' disease. Researchers want to see if it's safe and helps control thyroid hormone levels, aiming for them to be normal or lower, without needing more of current thyroid medication.
For: Grave's diseaseGermany - Ongoing, recruitingTherapeutic exploratory (Phase II)
An Open-Label Extension Study to Assess Long-term Safety and Tolerability of Batoclimab in Adult Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
This study looks at the long-term safety of a new medicine called Batoclimab for adults with a nerve condition called CIDP. It mainly checks for any side effects and how well people tolerate the treatment over time.
For: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Belgium · Denmark · Italy - Ongoing, recruitingTherapeutic confirmatory (Phase III)
An Open-label Extension Study for Participants who Completed Study IMVT-1401-3201 or Study IMVT-1401-3202 to Assess the Efficacy and Safety of Batoclimab for the Treatment of Thyroid Eye Disease (TED)
This study looks at a new medicine called batoclimab for Thyroid Eye Disease (TED). It’s for people who have already taken part in similar batoclimab studies. We want to see how long their eyes stay improved after stopping the medicine and if it helps those who didn't respond before.
For: Thyroid Eye Disease (TED)Slovakia · Hungary · Belgium